Editor-in-Chief

Prof. G. J. Peters
acting Head for the Laboratory Medical Oncology, VU University Medical Center, Netherlands. The major research interests of Prof. Peters include all aspects of pharmacology of anticancer agents, with emphasis on antifolates, other antimetabolites, platinum analogs, taxanes and more recently anti-signalling agents and third generation targeted-agents.

Senior Editors

Dr. Piero Picci
is presently acting as a Coordinator for IOR Director of the Laboratory of Experimental Oncology and President of the Italian Sarcoma Group and Director Laboratory of Experimental Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy. Dr. Piero is founder and member of the Board of the "Association for Study and Research in Musculo-skeletal Tumors". His major interest are focused on Diagnosis of bone tumors, Musculo-skeletal oncology, Bone tumors and Paediatric orthopaedic oncology.

Prof. Hallgeir Rui
Professor of Cancer Biology, Medical Oncology and Pathology at Thomas Jefferson University, Philadelphia, PA. He serves as the Scientific Director of the Jefferson Breast Care Center and is the Leader of Kimmel Cancer Center's Biology of Breast Cancer Program. Dr. Rui and his team have invented new high-density tissue arraying technology for high-throughput in situ biomarker studies. His major research interest focused on prolactin-JAK-STAT signaling in breast cancer, Loss of active STAT5 is an independent marker of poor prognosis and also an independent predictive marker of resistance to antiestrogen therapy.

Dr. Paolo Fortina
Professor of Cancer Biology, Jefferson Kimmel Cancer Center. He has completed his Ph.D. in Pediatrics, University of Turin School of Medicine, Torino, Italy. He is been acting as Adjunct Associate Professor of Pediatrics, University of Pennsylvania School of Medicine. His major research and Clinical Interest are focused on Genomics, technology and assay development in genomics, SNP genotype and CNV analysis for GWAS, gene discovery, pharmacogenomics .

Dr. Jacques E. Nor
Professor Of Cariology, Restorative Sciences, and Endodontics School of Dentistry, University of Michigan. He is been Honorary Professor, Oral Biology, University of Birmingham, UK. Dr. Nör research interests are focused on the cellular and molecular regulation of tumor angiogenesis. In addition, his research group has worked on the use of stem cells for the engineering of dental pulps.

Prof. Jiaoti Huang
Director, Urologic Pathology, Professor of Pathology and Laboratory Medicine. Dr. Jiaoti has Hospital Affiliation from Ronald Reagan UCLA Medical Center, USA. His research interested is majorly focused on Genitourinary Pathology, Surgical Pathology, Urologic Pathology.

Editorial Board

Dmitry Pshezhetskiy

University of East Anglia
United Kingdom

Stephen H. Safe

Texas A&M University
USA

Rossitza Lazova

Yale School of Medicine
USA

Guan Chen

Medical College of Wisconsin
USA

Hong Jiang

UT MD Anderson Cancer Center
USA

Stefan Octavian Ciurea

UT MD Anderson Cancer Center
USA

Bolin Liu

University of Colorado Denver
USA

Dario Marchetti

Baylor College of Medicine
USA

Jean-Baptiste Cazier

University of Birmingham
United Kingdom

Bechan Sharma

University of Allahabad
India

Gianluigi Mazzoccoli

IRCCS "Casa Sollievo della Sofferenza"
Italy